On February 24, 2026, NHS England published the GP contract changes for 2026/27. The BMA was not involved in negotiating it — DHSC described the process as a "consultation" rather than a negotiation, the first time they have openly used that language. GPC England has been in dispute with the Government since October 2025. And in March 2026, 99% of BMA GP members who voted rejected the contract outright.
Despite this, the contract is being imposed. The changes take effect from April 2026. Understanding them is not optional.
The Money
The headline: £485 million uplift, bringing the total GP contract value to approximately £13.86 billion. That sounds substantial. The reality is more complicated.
The 3.6% cash increase translates to approximately 1.4% real-terms growth after inflation. This includes a 2.5% pay assumption (subject to pay review body recommendations later in the year), funding for the QOF changes, and coverage for national cost pressures like premises inflation. Analysis from the Londonwide LMCs found that adjusting for 2.4% inflation, the contract value has actually reduced by 0.26% in real terms.
For comparison, the 2025/26 contract delivered a 7.2% cash increase (£969 million) — the largest in a decade. The 2026/27 increase is significantly smaller, and much of the 2025/26 headline was eroded by employer National Insurance increases and minimum wage rises.
Separately, £292 million is being repurposed from the PCN-level Capacity and Access Payment into a practice-level GP reimbursement scheme. This is not new money — it is existing funding moved from PCN control to practice control, working out to approximately £47,000 per average practice. The purpose: funding additional GPs or additional GP sessions to support same-day urgent access.
Same-Day Urgent Access
The most significant operational change. All patients identified as clinically urgent must be dealt with on the same day. Practices cannot ask patients to call back on another day for urgent needs.
The positive: it is for the practice to determine which requests are clinically urgent. The definition of "urgent" remains a clinical decision, not an administrative one.
The concern: this creates a hard floor of demand that must be met daily, regardless of staffing levels, annual leave, or unexpected capacity pressures. The £292 million GP reimbursement scheme is intended to fund the additional capacity, but many PCNs already use the equivalent funding for exactly this purpose — so the money is moving, not increasing.
Practices should model their same-day urgent demand now and determine whether additional GP sessions are required. If they are, the practice-level reimbursement scheme and expanded ARRS provide the funding routes.
QOF Changes
QOF is being updated to align with current NICE guidance. An additional 18 QOF points (approximately £25 million) support these changes. A new diabetes indicator requires delivery of all 8 NICE-recommended care processes — HbA1c, blood pressure, cholesterol, serum creatinine, urine ACR, foot examination, BMI, and smoking status. Two new obesity indicators support referrals into structured weight management programmes and medicines optimisation, including GLP-1 receptor agonist prescribing. Heart failure indicators are updated to reflect the NICE-recommended "four pillars" of treatment. New improvement thresholds for childhood vaccination indicators allow practices to earn points by improving from their own baseline. New BP indicators replace the previous CHD and stroke/TIA splits.
The iatroX Knowledge Centre provides instant access to the current NICE guidance underpinning each indicator, and Ask iatroX can verify any clinical detail in seconds.
Risk Stratification
It is now a core PCN requirement to use digital risk stratification tools to identify and prioritise cohorts for continuity of care. PCNs must demonstrate they are using these tools, have identified patients who benefit most from seeing the same GP consistently, and are acting on the intelligence.
Data Collection
NHS England will collect practice-level data against five access metrics: call waiting time between 8am and 10am, call waiting time during core hours, percentage of clinically urgent patients seen on the same day, percentage of non-clinically urgent patients seen within one week, and percentage of non-clinically urgent patients seen within two weeks. Practices must have cloud-based telephony capable of generating this data.
ARRS Changes
The restriction limiting ARRS GP funding to recently qualified GPs has been removed. Experienced GPs can now be recruited. The maximum reimbursement increases to £152,900 including on-costs outside London, and £155,698 in London.
Other Notable Changes
The Advice and Guidance Enhanced Service is retired and A&G funding moves into the core contract. Practices must use A&G prior to referral where clinically appropriate. New requirements include a dedicated GP email for pharmacy communications, mandatory data sharing with the Lung Cancer Screening Programme, mandatory online registration (paper forms must be entered digitally), stronger NICE NG12 cancer referral and safety-netting requirements, and participation in the General Practice Staff Survey.
What Happens Next
The contract is imposed despite the 99% rejection. GPC England continues to demand direct bilateral negotiations for a substantive GMS contract within this Parliament. Practices must implement the changes from April 2026.
iatroX provides instant access to the NICE guidance underpinning the QOF indicators, supports clinical reasoning for complex patients identified through risk stratification, and helps maintain the clinical knowledge that same-day urgent access demands — completely free.